CCMH
AMPH icon

Cornerstone Capital Management Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$4.91M Sell
255,300
-27,900
-10% -$521K 0.03% 464
2017
Q3 		$5.06M Buy
283,200
+5,000
+2% +$82.2K 0.04% 426
2017
Q2 		$4.97M Sell
278,200
-168,100
-38% -$2.67M 0.04% 444
2017
Q1 		$6.47M Buy
446,300
+92,181
+26% +$1.45M 0.05% 401
2016
Q4 		$6.52M Buy
354,119
+87,400
+33% +$1.7M 0.05% 397
2016
Q3 		$5.06M Buy
266,719
+118,800
+80% +$2.16M 0.04% 461
2016
Q2 		$2.38M Buy
147,919
+62,100
+72% +$876K 0.02% 680
2016
Q1 		$1.03M Buy
85,819
+48,400
+129% +$571K 0.01% 904
2015
Q4 		$532K Buy
37,419
+3,319
+10% +$43.8K ﹤0.01% 1025
2015
Q3 		$398K Buy
34,100
+15,900
+87% +$238K ﹤0.01% 1071
2015
Q2 		$320K Buy
+18,200
New +$284K ﹤0.01% 1103

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cornerstone Capital Management Holdings's AMPH Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Amphastar Pharmaceuticals (AMPH) stake by 9.9% in Q4 2017, selling an estimated $521K and leaving 255,300 shares worth $4.91M. The position accounts for 0.03% of the portfolio, ranked #464.

Cornerstone Capital Management Holdings first reported a position in AMPH in Q2 2015 and has held it in 11 quarters since. The position peaked at $6.52M in Q4 2016. 109 funds tracked by Wall St. Rank hold AMPH as of Q4 2017.

  • Cornerstone Capital Management Holdings held 255,300 shares of Amphastar Pharmaceuticals worth $4.91M as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 27,900 Amphastar Pharmaceuticals shares in Q4 2017, an estimated $521K.
  • Amphastar Pharmaceuticals made up 0.03% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #464 holding.
  • Cornerstone Capital Management Holdings first reported a position in Amphastar Pharmaceuticals in Q2 2015 and has held it in 11 quarters since.
  • Cornerstone Capital Management Holdings's Amphastar Pharmaceuticals position peaked at $6.52M in Q4 2016.
  • 109 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.